http://www.fpnotebook.com/
TrimethobenzamideAka: Tigan
- Indications
- Emesis of central causes
- Dosing
- Adults: 250 mg PO or 200 mg IM/PR q6-8 hours
- Child (15 to 40 kg): 100-200 mg PO/PR tid to qid
- Child (<15 kg): 100 mg PR tid to qid
- Do not use in newborns
- Mechanism
- Centrally acting non-phenothiazine Antiemetic
- References
- Johnson (1993) Harriet Lane, Mosby, p. 521
- (2002) Tarascon Pocket Pharmacopoeia, p. 67
trimethobenzamide (C0077163)
|
|---|
| Concepts | Organic Chemical (T109)
, Pharmacologic Substance (T121)
|
| English | trimethobenzamide, TRIMETHOBENZAMIDE PREPARATION |
| Spanish | trimetobenzamida |
| Credits | Derived from the NIH UMLS (Unified Medical Language System)
|
|
|---|
| Concepts | Organic Chemical (T109)
, Pharmacologic Substance (T121)
|
| English | Monarch brand of trimethobenzamide monohydrochloride, Tigan |
| Credits | Derived from the NIH UMLS (Unified Medical Language System)
|
Navigation Tree